New data highlight the many potential benefits of GLP-1 therapy GLP-1 RAs such as semaglutidesold by Novo Nordisk under the brand names Wegovy and Ozempiccontinue to be one of the most significant trends in modern medicine
Sign up for early access to sales, product launches, the latest Bulletproof news and more
Lower, customized dosages allow providers to closely monitor patients responses, reduce the likelihood of adverse effects, and tailor treatment to each patient's particular medical needs
Alpha Lipoic Acid reduces inflammation, minimises pore size, improves skin texture, and enhances the effectiveness of other actives in the formula delivering amplified, synergistic brightening results
Even more people have nutrient inadequacies---when intake of a nutrient is above the level usually associated with deficiency but below the estimated average requirement for healthy individuals---suggesting a potential for marginal deficiencies